Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.10.22
Comfort Systems USA Q3 EPS $13.91 Beats $12.50 Estimate, Sales $3.766B Beat $3.401B Estimate
Benzinga
2026.10.22
Vesta Real Estate Q3 FFO $0.05, Inline, Sales $79.600M Beat $78.634M Estimate
Benzinga
2026.10.22
Kinsale Cap Gr Q3 Adj. EPS $5.70 Beats $5.13 Estimate, Sales $454.798M Miss $476.731M Estimate
Benzinga
2026.10.22
Newmont Q3 Adj. EPS $2.20 Beats $2.08 Estimate, Sales $6.363B Beat $6.250B Estimate
Benzinga
2026.10.22
Universal Insurance Hldgs Q3 Adj. EPS $1.93 Beats $1.34 Estimate, Sales $439.319M Beat $385.438M Estimate
Benzinga
2026.10.22
Kilroy Realty Narrows FY2026 FFO Guidance from $3.49-$3.63 to $3.55-$3.59 vs $3.55 Est
Benzinga
2026.10.22
Orchid Island Cap Q3 Adj. EPS $0.27, Inline, Sales $59.134M Miss $61.020M Estimate
Benzinga
2026.10.22
SB Finl Gr Q3 2026 Earnings Call Transcript
Benzinga
2026.10.22
Vor Bio Announces Final Two-Year Results From Phase 3 TELIGAN Trial Evaluating Telitacicept In Adults With Iga Nephropathy; TELIGAN Met Stage B Primary Endpoint
Benzinga
2026.10.22
First Interstate BancSys Q3 EPS $0.65 Misses $0.68 Estimate, Sales $249.500M Beat $247.947M Estimate
Benzinga
2026.10.22
AppFolio Raises FY2026 Sales Guidance from $1.117B-$1.127B to $1.122B-$1.127B vs $1.124B Est
Benzinga
2026.10.22
Midland States Bancorp Q3 Adj. EPS $0.95 Beats $0.88 Estimate, Sales $85.959M Beat $83.774M Estimate
Benzinga
2026.10.22
SS&C Technologies Hldgs Narrows FY2026 Adj EPS Guidance from $6.93-$7.25 to $7.11-$7.17 vs $7.06 Est; Narrows FY2026 Sales Guidance from $6.672B-$6.832B to $6.736B-$6.776B vs $6.770B Est
Benzinga
2026.10.22
Fortrea And Omico Collaborate To Accelerate Precision Oncology Research By Helping Connect Cancer Patients To Biomarker-Matched Clinical Trials
Benzinga
2026.10.22
SS&C Technologies Hldgs Sees Q4 Adj EPS $1.88-$1.94 vs $1.90 Est; Sees Sales $1.700B-$1.740B vs $1.748B Est
Benzinga
2026.10.22
'COVID-Like' Cyberattack Wave Could Spread Beyond Crypto, Venture Capitalist Warns
Benzinga
2026.10.22
Deckers Outdoor Raises FY2027 GAAP EPS Guidance from $7.35-$7.50 to $7.80-$7.95 vs $7.50 Est; Lowers FY2027 Sales Guidance from $5.860B-$5.910B to $5.700B-$5.725B vs $5.882B Est
Benzinga
2026.10.22
Comfort Systems USA CFO Bill George To Retire; Julie Shaeff Named Successor
Benzinga
2026.10.22
Gilead Sciences Agrees To Acquire Oral IL-23R Inhibitor Program From PepStar Therapeutics Under $1.275B Deal
Benzinga
2026.10.22
Rexford Industrial Realty Raises FY2026 FFO Guidance from $2.38-$2.43 to $2.41-$2.44 vs $2.41 Est
Benzinga
2026.10.22
Robert Half Q3 EPS $0.49 Beats $0.47 Estimate, Sales $1.359B Beat $1.357B Estimate
Benzinga
2026.10.22
Nvidia's AI Warning, $111 Oil: Why SOXL Just Suffered a Brutal 20% Wipeout
Benzinga
2026.10.22
Knowles Sees Q4 GAAP EPS $0.31-$0.35 vs $0.28 Est
Benzinga
2026.10.22
Knowles Sees Q4 Adj EPS $0.39-$0.43 vs $0.38 Est; Sees Sales $180.000M-$190.000M vs $174.575M Est
Benzinga
2026.10.22
RingCentral Raises FY2026 Adj EPS Guidance from $4.96-$5.10 to $5.07-$5.12 vs $5.04 Est; Raises FY2026 Sales Guidance from $2.635B-$2.646B to $2.650B-$2.657B vs $2.641B Est
Benzinga
2026.10.22
Deckers Outdoor Q2 EPS $2.31 Beats $1.80 Estimate, Sales $1.481B Miss $1.507B Estimate
Benzinga
2026.10.22
Kilroy Realty Q3 FFO $0.88, Inline, Sales $266.750M Miss $267.412M Estimate
Benzinga
2026.10.22
WSFS Financial Q3 Adj. EPS $1.75 Beats $1.62 Estimate, Sales $287.600M Beat $197.423M Estimate
Benzinga
2026.10.22
SS&C Techs Hldgs Q3 Adj. EPS $1.78 Beats $1.77 Estimate, Adj. Sales $1.691B Beat $1.686B Estimate
Benzinga
2026.10.22
Danaher Posts First Earnings Under New CEO; Emphasizes Need For Improved Execution, Innovation
Benzinga
1
...
569
570
571
572
573
574
...
712
>